Technology | Guidewires | February 19, 2016

Nipro Medical Corp. Launches AquaLiner II Nitinol Guidewire in the U.S.

Hydrophilic, super-elastic second-generation guidewire provides control needed to navigate complex lesions

February 19, 2016 — Nipro North America announced the launch of the AquaLiner II second-generation 0.035-inch, hydrophilic, super-elastic nitinol guidewire. The guidewire enables the operator to navigate through complex lesions and deliver interventional devices such as balloons and stents.

AquaLiner II's improved, kink-resistant nitinol core provides the control needed to navigate the vasculature by absorbing strain and maintaining strength. The super-elasticity of the device’s core wire conforms to the patient's vasculature and provides excellent support for interventional devices.

The guidewire's hydrophilic coating delivers the durability required to maintain lubricity throughout the procedure even through multiple passes. AquaLiner II also delivers ienhanced tactile feel, pushability and trackability, even in the most challenging anatomy.

The chemically-engineered tip delivers a smooth, atraumatic insertion and navigation through vessels. Minimal force is required, allowing for better steerability and control. The tapered tip also provides optimal stability, while still maintaining a flexible soft taper.

AquaLiner II is available in various lengths, ranging from 150cm to 260cm, with a regular or stiff-configured wire and with a straight or angled tip.

For more information: www.nipro.com


Related Content

News | Cath Lab

May 13, 2026 — According to a recently released report, the global cath lab services market was valued at $46.0 billion ...

Home May 13, 2026
Home
News | Cath Lab

April 16, 2026 — A national study led by investigators from Cedars-Sinai Health Sciences University found that ...

Home April 20, 2026
Home
News | Cath Lab

April 6, 2026 —Stereotaxis has received U.S. Food and Drug Administration 510(k) clearance for its Synchrony system ...

Home April 07, 2026
Home
News | Cath Lab

March 31, 2026 — Solo Pace Inc. has announced the commercial release of the SoloPace Fusion Temporary Pacing System. The ...

Home April 03, 2026
Home
News | Cath Lab

March 25, 2026 — Royal Philips has launched its intuitive interventional guidance platform, IntraSight Plus, which is ...

Home March 26, 2026
Home
Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65 ...

Home October 29, 2025
Home
News | Cath Lab

Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance ...

Home October 28, 2025
Home
Subscribe Now